IQVIA Consumer Health Perspectives
As we enter the final months of 2023, two key factors continue to dominate the global OTC market – the rebound of cough, cold and respiratory product sales and the impact of inflation on pricing and the cost of living.??
Driven by these factors, the global OTC market to MAT Q2 2023 posted growth of 8.5% to US$187 billion – which while slower than the prior year period, it is still well ahead of the pre-COVID levels.?
Welcome to IQVIA Consumer Health Perspectives, our latest thinking on various key issues shaping the consumer health industry across the world.
Latin America, EMEA and APAC posted strong double-digit growth through the 2023 Q2 MAT period. Firms with CCR-weighted portfolios outperformed overall market growth, with P&G driven by Vicks, Reckitt driven by Mucinex and Stada driven by Grippostad leading the growth over the period. Germany-based Stada was the standout performer, with the company’s overall Consumer Health sales growing by 12.6%.
Although many Consumer Health organizations have an existing Master Data Management strategy, it is no surprise that siloed data is still a reoccurring pain point, costing time and money to resolve. Discover how you can effectively address your data harmonization by harnessing the robust matching capabilities of IQVIA Data Bridging. Join us for the free short 30 minute online webinar on October 17th.???
Download The Next Generation of Rx-to-OTC Switch, featuring experts from Concentrics Research - an IQVIA business, IQVIA Consumer Health, along with Haleon’s Vice President, Rx to OTC Switch and Digital Transformation, Vidhu Dev. The race is on to drive the next generation of non-prescription medicines and shape the self-care future.?
领英推荐
We hope our 2023 IQVIA Consumer Health thought leadership content has helped drive you and your brands forward. We want to ensure we bring you the insights you need in 2024. Please help us by completing this very short survey. We appreciate and value your feedback, and look forward to bringing you further editions of IQVIA Consumer Health Perspectives in 2024. Thank you.?
As the dust settles, one thing is clear — multi-channel engagement remains challenging but crucial to ensuring consumer health brand success. It will be imperative for the Consumer Health industry to ‘get smart’ in the age of omnichannel engagement, using various approaches to offer seamless, value-adding engagement experiences for HCPs.
If you have any questions, or want to get in touch to discuss potential future topics you would like the IQVIA Consumer Health team to tackle, please feel free to email us at [email protected].
If you wish to receive Perspectives via email in future, you can be subscribe here, ensure the “Opt In” box is ticked.
Kind Regards,?
Vincent Bartkowiak
Sr. Director, Global Business Marketing
IQVIA Consumer Health